| Literature DB >> 27335754 |
Bin Song1, Yanli Zhang2, Jia Liu2, Xiaoli Feng2, Ting Zhou3, Longquan Shao2.
Abstract
Titanium dioxide nanoparticles (TiO2 NPs) possess unique characteristics and are widely used in many fields. Numerous in vivo studies, exposing experimental animals to these NPs through systematic administration, have suggested that TiO2 NPs can accumulate in the brain and induce brain dysfunction. Nevertheless, the exact mechanisms underlying the neurotoxicity of TiO2 NPs remain unclear. However, we have concluded from previous studies that these mechanisms mainly consist of oxidative stress (OS), apoptosis, inflammatory response, genotoxicity, and direct impairment of cell components. Meanwhile, other factors such as disturbed distributions of trace elements, disrupted signaling pathways, dysregulated neurotransmitters and synaptic plasticity have also been shown to contribute to neurotoxicity of TiO2 NPs. Recently, studies on autophagy and DNA methylation have shed some light on possible mechanisms of nanotoxicity. Therefore, we offer a new perspective that autophagy and DNA methylation could contribute to neurotoxicity of TiO2 NPs. Undoubtedly, more studies are needed to test this idea in the future. In short, to fully understand the health threats posed by TiO2 NPs and to improve the bio-safety of TiO2 NPs-based products, the neurotoxicity of TiO2 NPs must be investigated comprehensively through studying every possible molecular mechanism.Entities:
Keywords: DNA methylation; autophagy; brain; neurotoxicity; titanium dioxide nanoparticles
Year: 2016 PMID: 27335754 PMCID: PMC4901937 DOI: 10.3762/bjnano.7.57
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.649
Mechanisms of neurotoxicity of titanium dioxide nanoparticles in in vivo studies.
| objects | administration route | mechanisms of neurotoxicity | references |
| rats | intravenous injection | indirect mechanism (induced by cytokines and pro-inflammatory mediators in systemic circulation) | [ |
| mice | nasal administration | inflammatory response (over-proliferation in glia cells) | [ |
| rats | intravenous injection | OS and angiotensin system | [ |
| rats | intravenous injection | multiple (OS, inflammatory response and DNA damage) | [ |
| mice | oral administration | OS (ROS and anti-oxidant enzymes disturbed) | [ |
| mice | inhalation | OS (H2O2 and MDA elevated) | [ |
| mice | oral administration | other mechanisms | [ |
| mice | intranasal administration | inflammatory response | [ |
| pregnant rats | subcutaneous injection | OS | [ |
| pregnant rats | oral administration | other mechanisms (cell proliferation inhibited) | [ |
| pregnant mice | subcutaneous injection | other mechanisms (disrupted dopamine systems) | [ |
| pregnant mice | subcutaneous injection | multiple mechanisms (apoptosis, OS and neurotransmitters) | [ |
| mice | nasal instillation | OS | [ |
| mice | nasal instillation | multiple mechanisms (OS and inflammatory response) | [ |
| mice | delivery in abdominal cavity | OS | [ |
| mice | intragastric administration | other mechanisms (disturbed distributions of trace elements, enzymes and neurotransmitters) | [ |
| mice | intragastric administration | multiple mechanisms (apoptosis and OS) | [ |
| mice | intranasal administration | P38-Nrf-2-mediated OS | [ |
| neonatal rats | lactation exposure orally | disturbed synaptic plasticity | [ |
| rats | trachea administration | inflammatory response | [ |
| mice | injection in abdominal cavity | genotoxicity induced by OS | [ |
Main mechanisms of neurotoxicity of titanium dioxide nanoparticles in in vitro studies.
| cell types | mechanisms of neurotoxicity | references |
| BV2 | OS (ROS, H2O2 elevated) | [ |
| primary hippocampal neurons | multiple mechanisms (disrupted glutamate metabolism and dysregulated levels of NMDARs) | [ |
| primary hippocampal neurons | apoptosis mediated by mitochondria- and endoplasmic reticulum-pathways | [ |
| primary astrocytes | direct impairment of mitochondria and ROS | [ |
| D384 and SH-SY5Y | direct impairment of mitochondria and cell membrane | [ |
| SH-SY5Y | direct impairment of microtubules and cell morphology | [ |
| SH-SY5Y | multiple mechanisms (changed cell cycle, apoptosis, and DNA damage) | [ |
| C6 and U373 | OS and impairment of mitochondria | [ |
| C6 and U373 | multiple mechanisms (inhibited cell proliferation, morphological change and apoptosis) | [ |
| N9 | apoptosis | [ |
| U87 | apoptosis | [ |
| PC12 | multiple mechanisms (OS and apoptosis) | [ |
| PC12 | other mechanisms (signaling pathway activated and arrested cell cycle) | [ |
Autophagy and DNA methylation in non-neuronal cells induced by TiO2 NPs.
| cell type | mechanisms | references |
| normal lung cell | autophagy | [ |
| primary human keratinocytes | autophagy | [ |
| A549 | DNA methylation | [ |